Skip to main content

Table 1 Demographic characteristics

From: Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey

Characteristic

Total

Patients, N

448

HAE diagnosis, n (%)

 Type 1

423 (94.4)

 Type 2

25 (5.6)

Sex, n (%)

 Female

263 (58.7)

 Male

185 (41.3)

Age at enrollment, y

 Mean (SD)

40.8 (14.7)

 Median (min, max)

39.1 (16.5, 81.8)

Country, n (%)

 France

119 (26.6)

 Spain

69 (15.4)

 Germany

57 (12.7)

 United Kingdom

53 (11.8)

 Italy

46 (10.3)

 Israel

45 (10.0)

 Denmark

19 (4.2)

 Brazil

16 (3.6)

 Greece

14 (3.1)

 Austria

8 (1.8)

 Sweden

2 (0.4)

  1. HAE hereditary angioedema, max maximum, min minimum